Landmark UK-US pharmaceuticals deal to safeguard medicines access and drive vital investment for UK patients and businesses
GOV.UK3 days
UK Secures Zero Tariffs on US Pharma Exports in Trade Deal
UK Secures Zero Tariffs on US Pharma Exports in Trade Deal
Above: A chemist displays at the Glastonbury Festival on June 26, 2025. Image credit: Matt Cardy/Getty Images
The Spin
The U.S.-UKU.K. deal forces taxpayers to pay an extra £3 billion while the NHS budget for medicines balloons from 9.5% to 12%. It raises drug prices by 25% and weakens cost-effectiveness standards that protected patients from overpriced treatments, all to appease Trump's demand that Europe subsidize U.S. pharmaceutical profits.
This landmark agreement finally ends decades of Britain freeloading off American patients who've been forced to subsidize the world's drug costs. The deal secures zero tariffs on £5 billion worth of UKU.K. pharmaceutical exports while ensuring fair pricing that will fuel innovation and bring cutting-edge treatments to patients.
Metaculus Prediction
There is a 50% chance that. at least 69 drugs will be approved by the FDA in 2035, according to the Metaculus prediction community.
The Controversies
Articles on this story
© 2025 Improve the News Foundation. All rights reserved.Version 6.18.0
© 2025 Improve the News Foundation.
All rights reserved.
Version 6.18.0